Switching From Semaglutide to Tirzepatide: What to Ask Your Provider

Switching from semaglutide to tirzepatide is a decision your prescribing provider makes with you, and the Zepbound label gives no switching instructions. So when to stop one, when to start the other, and at what dose are all your provider’s calls. What you can do is arrive with the right questions. This guide lists them, with the label facts that sit behind a few of them.

This article is general information, not medical advice, a dose recommendation or a conversion chart. Your prescribing provider sets your dose.

Can you switch from semaglutide to tirzepatide?

A provider can move you from one medicine to the other if it makes sense for you. Both are GLP-1 based medicines, and tirzepatide is the active ingredient in Zepbound and Mounjaro. Semaglutide is the active ingredient in Wegovy and Ozempic. What matters here is what the label does and does not say.

Two points from the Zepbound prescribing information on DailyMed (updated August 2026 when we checked):

• The Medication Guide says Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. Semaglutide is one of those, so the two are not meant to be taken together.
• The label does not include a step-by-step plan for switching from another GLP-1 medicine. We searched the full text. The only mentions of “switch” are about birth control and a clinical trial arm.

That gap is the reason to ask your provider and not guess. Nobody should hand you a conversion number from a forum post.

What should you ask about your reason for switching?

Start with why. Different reasons lead to different plans, and your provider can only help if they know yours.

• “Is switching the right next step for me?” Weight loss that has slowed, side effects you cannot live with, or a change in your health can each point somewhere different. Sometimes the answer is to stay put.
• “What are we hoping the change will do?” Agree on a goal and a time to review it, so you both know how to judge whether it helped.
• “Is there anything about my history that matters here?” Tell your provider about past stomach problems, pancreas or gallbladder problems, and any kidney issues.

Our comparison page, tirzepatide vs semaglutide for weight loss, is a good read before this conversation.

What should you ask about timing and your plan?

These are the questions the label leaves open, so they are the ones to settle in writing:

• “When should I take my last semaglutide dose?”
• “When is my first tirzepatide dose, and what dose will it be?” Ask your provider to explain the reasoning. Our guide to the starting dose of compounded tirzepatide shows how the clinic’s published schedule works, but your own plan comes from your provider.
• “How will the dose change from here?” Ask how often it may step up and what would make you pause.
• “What do I do if I miss a dose or feel unwell during the change?”

Write the answers down, including the dates. A clear calendar helps you avoid taking both medicines by mistake.

What should you ask about your other medicines and health?

The Zepbound label raises several points that are worth putting on the table when you switch:

• Birth control. The label advises people who use oral hormonal contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting Zepbound and for 4 weeks after each dose increase. Ask whether that applies to you.
• Diabetes medicines. The label says Zepbound lowers blood sugar. In a trial of people with type 2 diabetes, low blood sugar was reported in 10.3% of people also taking a sulfonylurea, against 2.1% of those who were not. If you take insulin or a sulfonylurea, ask whether those doses need a review.
• Surgery or sedation. The label says Zepbound delays stomach emptying and notes rare reports of food or liquid entering the lungs during anesthesia or deep sedation in people taking GLP-1 medicines. Tell any team planning a procedure which medicine you take.
• Safety warnings. Zepbound carries a boxed warning about thyroid C-cell tumors seen in rats, and it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Check that your provider has your full history.

What should you ask about the product and pharmacy?

• “Which form of tirzepatide is this?” Brand-name and compounded medicines are different things. We explain how in is tirzepatide the same as Zepbound.
• “Which pharmacy supplies it, and what strength and vial size will I get?” Strength and vial size decide how many units you draw, so make sure you understand your own instructions. Our GLP-1 vial calculator can help you follow a plan your provider has already given you.
• “What will it cost each month?” See the current plans on our tirzepatide pricing and programs page and ask what is included.

What should you ask about side effects and follow-up?

• “Which side effects are normal for me, and which mean I should call?” A new medicine can bring back nausea or tiredness even if your last one was easy to tolerate. See our guide to side effects as the dose changes.
• “How will we keep track?” Ask about check-ins, what to log, and who to contact between visits.
• “What happens once I reach my goal?” Our article on the tirzepatide maintenance dose after weight loss looks at that stage.

Frequently asked questions

Sources

• Zepbound prescribing information and Medication Guide (DailyMed)

More from this guide series

• Does tirzepatide make you tired? What the label says.
• Is tirzepatide the same as Zepbound? Brand vs compounded, according to FDA.
• Tirzepatide maintenance dose after weight loss: what the next stage looks like.

Next step

To see whether a prescribed GLP-1 is right for you, start the free intake form. The clinic will contact you to schedule an appointment, and a licensed provider reviews your health before anything is prescribed.